Business
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES.
About this update from Hemogenyx Pharmaceuticals Plc
[{"type":"text","content":"\n \n \n RNS Number : 1156O\n Hemogenyx Pharmaceuticals PLC\n 27 May 2020\n \n \n \n \n \n TR-1: S\n \n \n tandard form for notification of major holdings\n \n \n \n \n \n \n \n \n \n \n \n NOTIFICATION OF MAJOR HOLDINGS\n \n \n \n \n (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)\n \n i\n \n \n \n \n \n \n \n \n \n \n \n \n \n 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached\n \n \n ii\n \n \n :\n \n \n \n \n \n \n HEMOGENYX \n PHARMACEUTICALS PLC\n \n \n \n \n \n \n \n 1b. Please indicate if the issuer is a non-UK issuer \n \n (please mark with an \"X\" if appropriate)\n \n \n \n \n \n \n Non-UK issuer\n \n \n \n \n \n \n \n \n \n \n 2. Reason for the notification \n \n (please mark the appropriate box or boxes with an \"X\")\n \n \n \n \n \n \n An acquisition or disposal of voting rights\n \n \n \n \n \n \n \n \n \n An acquisition or disposal of financial instruments\n \n \n \n \n \n \n \n \n \n An event changing the breakdown of voting rights\n \n \n \n \n x\n \n \n \n \n \n \n Other (please specify)iii:\n \n \n \n \n \n \n \n \n \n \n 3. Details of person subject to the notification obligation\n \n \n iv\n \n \n \n \n \n \n \n Name\n \n \n \n \n Craig Auringer\n \n \n \n \n \n \n City and country of registered office (if applicable)\n \n \n \n \n London UK\n \n \n \n \n \n \n \n 4. Full name of shareholder(s)\n \n (if different from 3.)\n \n v\n \n \n \n \n \n \n \n Name\n \n \n \n \n \n \n \n \n \n City and country of registered office (if applicable)\n \n \n \n \n \n \n \n \n \n \n 5. Date on which the threshold was crossed or reached\n \n \n vi\n \n \n :\n \n \n \n \n \n May 26 ,2020\n \n \n \n \n \n \n 6. Date on which issuer notified (DD/MM/YYYY):\n \n \n \n \n May 27, 2020\n \n \n \n \n \n \n 7. Total positions of person(s) subject to the notification obligation 27\n \n \n \n \n \n \n \n \n \n % of voting rights attached to shares (total of 8. A)\n \n \n \n \n % of \n voting rights through \n financial instruments\n(total of 8.B 1 + 8.B 2)\n \n \n \n \n Total of both in % (8.A + 8.B)\n \n \n \n \n Total number of voting rights of issuer\n \n vii\n \n \n \n \n \n \n \n Resulting situation on the date on which threshold was crossed or reached\n \n \n \n...